CO107 Progression-Free Survival in Patients with Advanced or Metastatic, Hormone Receptor Positive, HER2-Negative Breast Cancer Treated with Palbociclib in Combination with Fulvestrant: A Real-World Study
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.203
https://www.valueinhealthjournal.com/article/S1098-3015(22)00404-1/fulltext
Title :
CO107 Progression-Free Survival in Patients with Advanced or Metastatic, Hormone Receptor Positive, HER2-Negative Breast Cancer Treated with Palbociclib in Combination with Fulvestrant: A Real-World Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00404-1&doi=10.1016/j.jval.2022.04.203
First page :
Section Title :
Open access? :
No
Section Order :
10172